Wolverine Trading’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$482K Buy
40,000
+27,300
+215% +$255K ﹤0.01% 3755
2025
Q2
$83.2K Sell
12,700
-12,000
-49% -$78.9K ﹤0.01% 4205
2025
Q1
$153K Sell
24,700
-14,500
-37% -$104K ﹤0.01% 4079
2024
Q4
$263K Buy
39,200
+5,300
+16% +$36.5K ﹤0.01% 4176
2024
Q3
$198K Sell
33,900
-7,100
-17% -$49.4K ﹤0.01% 4105
2024
Q2
$296K Sell
41,000
-4,900
-11% -$42.9K ﹤0.01% 3405
2024
Q1
$431K Buy
45,900
+25,300
+123% +$144K ﹤0.01% 2988
2023
Q4
$75.4K Sell
20,600
-900
-4% -$2.71K ﹤0.01% 4164
2023
Q3
$67.3K Sell
21,500
-10,600
-33% -$43.6K ﹤0.01% 4111
2023
Q2
$111K Buy
32,100
+13,600
+74% +$46.9K ﹤0.01% 3741
2023
Q1
$57K Buy
18,500
+3,600
+24% +$12K ﹤0.01% 3805
2022
Q4
$33K Sell
14,900
-46,600
-76% -$129K ﹤0.01% 3666
2022
Q3
$212K Buy
+61,500
New +$590K ﹤0.01% 3541
2022
Q1
Sell
-2,827
Closed -$61K 6060
2021
Q4
$61K Sell
2,827
-1,033
-27% -$33K ﹤0.01% 5264
2021
Q3
$136K Sell
3,860
-2,233
-37% -$96.5K ﹤0.01% 5611
2021
Q2
$329K Buy
+6,093
New +$320K ﹤0.01% 4287

Other funds holding DFTX

Wolverine Trading's DFTX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Definium Therapeutics (DFTX) in Q3 2025: 60,250 shares worth $725K. The stake represents ﹤0.01% of the portfolio and ranks #3260 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in DFTX as recently as Q1 2025.

Wolverine Trading first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • Wolverine Trading held 60,250 shares of Definium Therapeutics worth $725K as of Q3 2025.
  • Definium Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Definium Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3260 holding.
  • Wolverine Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.